Q? 2B or not 2B Outrageous fortuneWell, is it any wonder that the street is extolling the great virtues of Tahera, another junior which is inferior in many aspects when compared directly to Randsburg? The diamond junior sector companies compete for investment from the public, so this makes Tahera and others into competitors of RGZ. Hiring AGORA does not get us the exposure necessary to generate high daily volume like TAH, despite our great fundamentals, which would wake up many who invest in this sector who seem to be unaware of the intrinsic differences and overvaluation or undervaluation relative to each particular stock. It seems that the powers that be, don't want the Randsburg story to get out into the media, since the other stocks probably would suffer from capital flight out of those stocks and into RGZ instead. Therefore, the word is to keep RGZ out of the limelight until they are ready which would not adversely affect their open stock positions in these competitors. Just imagine where we would be trading if Randsburg were trading 889,000 shares halfway through one trading day! This is rather unlikely since we ONLY have roughly 20 million shares diluted, and not 800 million like Tahera. Perhaps, management needs a specialist in marketing to set the market right and alert the investing public as to RGZ, an overlooked, severely undervalued opportunity. If enough Randsburgians continue to bang their heads against a brick wall, maybe the demand for titanium plate will cause the price to rise in order to repair all those damaged craniums. Perhaps that is when we will see RGZ stock increase in price! Yes, titanium craniums, that's it. If we can't get any play from diamonds, then we'll try the titanium angle. Is this treatment outrageous, or are we on the verge of outrageous fortune? Audaces Fortuna iuvat! RGZ is quietly being accumulated by the pros here. https://www.artofeurope.com/shakespeare/sha8.htm https://www.yuni.com/library/latin.html